1Jing Y. The PML - RAR alpha fusion protein and targeted therapy for acute promyelocytic leukemia [J]. Leuk Lymphoma, 2004 Apr, 45(4) :639 -48.
2Reilly JT. Pathogenesis of acute myeloid leukaemia and inv ( 16 ) (p13;q22) : a paradigTn for understanding leukaemogenesis? [J].Br J Haematol,2005 Jan, 128 ( 1 ) : 18 - 34.
3Yamamoto M, Kakihana K, Kurosu T, Murakami N, Miura O. Clonal evolution with inv( 11 )(p15q22) and NUP98/DDX10 fusion gene in imatinib - resistant chronic myelogenous leukemia [J]. Cancer Genet Cytogenet ,2005 Mar. 157 ( 2 ) : 104 - 8.
4Gunawan B, Schulten HJ, von Heydebreck A, Schmidt B, Enders C, Hoer J, Langer C, Schuler P, Schindler CG, Kuhlgatz J, Fuzesi L. Site - independent prognostic value of chromosome 9q loss in primary gastrointestinal stromal tumours [J]. J Pathol, 2004 Apr, 202(4) :421 -9.
5Stallings RL, Carry P, McArdlc L, Mullarkey M, McDermott M,Breatnach F, OMeara A. Molecular cytogcnetic analysis of recurrent unbalanced t(11;17)in neurob lastoma[J]. Cancer Genet Cytogenct,2004 Oct 1.154( 1 ) :44 -51.
6Head E, Lott IT. Down syndrome and beta - amyloid deposition[J]. Curt Opin Neurol, 2004 Apr, 17(2):95- 100.
7Helguera P, Pelsman A, Pigino G, Wolvetang E, Head E, Busciglio J. ets -2 promotes the activation of a mitochondrial death pathway in Down's syndrome neurons[J]. J Neurosci,2005 Mar 2,25(9) :2295 - 303.
8Lichiardopol C, Mota M. Cardiovascular risk factors in Turner syndrome[J]. Rom J Intern Med, 2004,42(2) :371 -9.
9Bouayed Abdelmoula N, Portnoi MF, Keskes L, Recan D, Bahloul A, Boudawara T, Saad A, Rebai T. Skewed X - chromosome inactivation pattern in SRY positive ⅩⅩ maleness: a case report and review of literature[J]. Ann Genet, 2003 Jan - Mar,46( 1 ) : 11 - 8.
